Form 4: Mereo BioPharma CFO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Christine Ann Fox, CFO of Mereo BioPharma Group plc, sold shares to cover tax withholding obligations related to vested restricted stock units.
Summary
- Christine Ann Fox, the Chief Financial Officer of Mereo BioPharma Group plc, reported the sale of American Depositary Shares (ADS) representing ordinary shares.
- The sales occurred on September 12, 2024, and September 13, 2024.
- These transactions were to cover tax withholding obligations related to the vesting of performance-based restricted stock units under the company's 2019 Employee Incentive Plan.
- On September 12, 2024, 9,128 ADSs were sold at a weighted average price of $4.4727.
- On September 13, 2024, 19,158 ADSs were sold at a weighted average price of $4.221.
- Following these transactions, Fox directly owns 89,285 ADSs.
Sentiment
Score: 6
Explanation: The document reflects a routine transaction (sale of shares to cover taxes) and doesn't indicate any significant positive or negative sentiment regarding the company's performance or future prospects.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives.
Key Dates
| Date | Description |
|---|---|
| 09/12/2024 | Sale of 9,128 American Depositary Shares at a weighted average price of $4.4727. |
| 09/13/2024 | Sale of 19,158 American Depositary Shares at a weighted average price of $4.221. |
| 09/16/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.